Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify or Tylenol autism cases. Thank you.
Select Page

Adverse Events Linked to the Drug Xeljanz

Xeljanz has been marketed and sold to consumers in the United States for nearly a decade, manufactured by the Pfizer pharmaceutical company. Xeljanz and Xeljanz XR are the brand names for the drug tofacitinib. Xeljanz is in a class of drugs called Janus Kinase (JAK) inhibitors that lower the immune system. It is a popular prescription drug to treat the symptoms of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. The mechanism of the drug is to inhibit the enzymes that inflame and damage joints, which cause arthritis. It disrupts the pathways of the cells that play a role in the inflammation process of ulcerative colitis. The Food and Drug Administration approved Xeljanz in November 2012 for patient consumption to treat rheumatoid and psoriatic arthritis and in 2018 for ulcerative colitis.

Xeljanz has been Linked to Severe Illness and Mortality

Xeljanz is associated with an increased risk for infections, pulmonary embolisms, deep vein thrombosis, perforations of the stomach and intestines, cardiovascular events, and liver damage. In addition, Xeljanz is associated with developing cancer, and taking higher doses increases the risk. Medical studies and clinical trials have connected Xeljanz to potentially fatal malignancies, including non-melanoma and melanoma skin cancers, lymphoma, lung, breast, gastric, pancreatic, and prostate cancer. Patients taking Xeljanz and experiencing symptoms such as shortness of breath, chest pain, coughing blood, swelling, pain, redness in the extremities, jaundice, excessive sweating, weight loss, or fever should immediately seek medical attention.

Black Box Warning Instituted

Following a post-marketing safety study on Xeljanz, the Food and Drug Administration issued safety alerts in 2019 and 2021 warning of potential risks of blood clots, cancer, and cardiovascular problems linked to this drug. They issued a black box warning, the highest safety-related warning that drugs are assigned, to bring the consumer’s attention to the potential consequences.

Claims against Pfizer Incorporated

There are allegations that the Pfizer pharmaceutical company has minimized the risks of Xeljanz on the warning label. They have failed to adequately research the drug before selling it to consumers, provide accurate and adequate warnings about the drug’s adverse events and side effects, or issue a recall of the drug. Countless numbers of people are suffering adverse events and filing claims against Pfizer. These lawsuits will likely be consolidated into a class action and multidistrict litigation in the near future.

Contact a Highly Respected Nationwide Complex Litigation Law Firm

If you or a loved one experienced adverse effects after taking the drug Xeljanz, you may be eligible to file a Xeljanz lawsuit. A Xeljanz lawsuit may help obtain compensation for medical bills, lost wages, pain and suffering, and other damages. At the Michael Brady Lynch Firm, we know that victims of defective drugs and their families are often left with unanticipated financial instability and emotional pain. Our legal team is passionate about holding the pharmaceutical industry accountable. We are well versed in complex pharmaceutical litigation and have a record of proven results on behalf of our clients.

Call us today to schedule a no-obligation consultation at (888)585-5970. We represent personal injury and pharmaceutical claims for clients throughout the country. The Michael Brady Lynch Firm is a fierce advocate committed to your success.

Sources:

https://www.drugwatch.com/xeljanz/lawsuits

https://www.fda.gov/news-events/fda-brief/fda-brief-fda-responds-safety-signal-reported-required-postmarketing-trial-xeljanz

 

 

Injured on a Cruise Ship? Call Us

Injured on a Cruise Ship? Call Us

Cruise vacations promise relaxation and adventure, but accidents do happen. Injuries aboard cruise ships can range from minor incidents to severe accidents, raising complicated legal questions about liability and compensation.

read more
Suboxone Lawsuits: From Opioid Addiction Cure to MDL Defendant

Suboxone Lawsuits: From Opioid Addiction Cure to MDL Defendant

According to the National Center for Biotechnology Medicine, more people die from drug overdoses in the US than any other form of accidental death. Opioid overdoses outnumber the historical peak death rate of HIV, gun violence, and car crashes. There’s no doubt we’re in the middle of an opioid crisis. Often, people become addicted to this drug after a legitimate prescription to manage pain after surgery or a chronic pain condition.

read more
Video Game Lawsuits: Developers Face Legal Action for Addictive Gameplay

Video Game Lawsuits: Developers Face Legal Action for Addictive Gameplay

Over the past 20 to 30 years, studies and mainstream media outlets have blamed video games for desensitizing minors to violence, increased obesity rates, sedentary lifestyles, and mental health issues like depression and anxiety. Now, developers are facing video game lawsuits from gamers who have become addicted to video games. Learn more about video game addiction and what to do if you or a loved one have suffered from video game addiction below.

read more
Ozempic Lawsuit 2024: The Latest Updates

Ozempic Lawsuit 2024: The Latest Updates

The FDA has approved Ozempic, a medication manufactured by Dutch company Novo Nordisk, for treating type 2 diabetes. Many healthcare providers also prescribe Ozempic to their patients for weight management purposes. This is because the medication’s active ingredient, semaglutide, has been approved for weight loss treatments.

read more
PFAS Lawsuit Update: March 2024

PFAS Lawsuit Update: March 2024

Suboxone, a medication approved by the FDA for the treatment of opioid addiction, has garnered significant attention not just within medical circles but also in legal domains. Composed of buprenorphine and naloxone, Suboxone has been lauded for its effectiveness in reducing opioid withdrawal symptoms and cravings. However, its rise in use has been shadowed by a growing concern over its potential for abuse, dependency, and the risk of serious side effects.

read more
×
What Our Clients Are Saying